amphetamine has been researched along with myelin oligodendrocyte glycoprotein (35-55) in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullitta, S; Centonze, D; De Vito, F; Fantozzi, R; Fresegna, D; Gentile, A; Lutz, B; Maccarrone, M; Mandolesi, G; Mercuri, NB; Musella, A; Sepman, H; Usiello, A | 1 |
1 other study(ies) available for amphetamine and myelin oligodendrocyte glycoprotein (35-55)
| Article | Year |
|---|---|
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis.
Topics: Amphetamine; Animals; Antirheumatic Agents; Anxiety; Central Nervous System Stimulants; Cerebral Cortex; Corpus Striatum; Dark Adaptation; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Excitatory Amino Acid Antagonists; Exploratory Behavior; Female; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Mice; Mice, Inbred C57BL; Mice, Knockout; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Receptor, Cannabinoid, CB1; Signal Transduction | 2016 |